183 related articles for article (PubMed ID: 35682709)
1. PLOD2 Is a Prognostic Marker in Glioblastoma That Modulates the Immune Microenvironment and Tumor Progression.
Kreße N; Schröder H; Stein KP; Wilkens L; Mawrin C; Sandalcioglu IE; Dumitru CA
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682709
[TBL] [Abstract][Full Text] [Related]
2. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
[TBL] [Abstract][Full Text] [Related]
3. PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer.
Li G; Wang X; Liu G
Biomed Res Int; 2021; 2021():5512340. PubMed ID: 34258263
[TBL] [Abstract][Full Text] [Related]
4. Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes hypoxia-induced glioma migration and invasion.
Xu Y; Zhang L; Wei Y; Zhang X; Xu R; Han M; Huang B; Chen A; Li W; Zhang Q; Li G; Wang J; Zhao P; Li X
Oncotarget; 2017 Apr; 8(14):23401-23413. PubMed ID: 28423580
[TBL] [Abstract][Full Text] [Related]
5. PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics.
Sheng X; Li Y; Li Y; Liu W; Lu Z; Zhan J; Xu M; Chen L; Luo X; Cai G; Zhang S
BMC Cancer; 2019 Aug; 19(1):840. PubMed ID: 31455288
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significances of PLOD2, epithelial-mesenchymal transition markers, and cancer stem cells in patients with esophageal squamous cell carcinoma.
Gong X; Wang A; Song W
Medicine (Baltimore); 2022 Aug; 101(34):e30112. PubMed ID: 36042592
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-Induced PLOD2 is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer.
Okumura Y; Noda T; Eguchi H; Sakamoto T; Iwagami Y; Yamada D; Asaoka T; Wada H; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
Ann Surg Oncol; 2018 Nov; 25(12):3728-3737. PubMed ID: 30105440
[TBL] [Abstract][Full Text] [Related]
8. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
9. PLOD2 induced under hypoxia is a novel prognostic factor for hepatocellular carcinoma after curative resection.
Noda T; Yamamoto H; Takemasa I; Yamada D; Uemura M; Wada H; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
Liver Int; 2012 Jan; 32(1):110-8. PubMed ID: 22098155
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced PLOD2 regulates invasion and epithelial-mesenchymal transition in endometrial carcinoma cells.
Wan J; Qin J; Cao Q; Hu P; Zhong C; Tu C
Genes Genomics; 2020 Mar; 42(3):317-324. PubMed ID: 31872384
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced PLOD2 promotes proliferation, migration and invasion via PI3K/Akt signaling in glioma.
Song Y; Zheng S; Wang J; Long H; Fang L; Wang G; Li Z; Que T; Liu Y; Li Y; Zhang X; Fang W; Qi S
Oncotarget; 2017 Jun; 8(26):41947-41962. PubMed ID: 28410212
[TBL] [Abstract][Full Text] [Related]
12. PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.
Kiyozumi Y; Iwatsuki M; Kurashige J; Ogata Y; Yamashita K; Koga Y; Toihata T; Hiyoshi Y; Ishimoto T; Baba Y; Miyamoto Y; Yoshida N; Yanagihara K; Mimori K; Baba H
Int J Cancer; 2018 Sep; 143(5):1202-1211. PubMed ID: 29603227
[TBL] [Abstract][Full Text] [Related]
13. PLOD2 promotes aerobic glycolysis and cell progression in colorectal cancer by upregulating HK2.
Du W; Liu N; Zhang Y; Liu X; Yang Y; Chen W; He Y
Biochem Cell Biol; 2020 Jun; 98(3):386-395. PubMed ID: 31742425
[TBL] [Abstract][Full Text] [Related]
14. Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression.
He JY; Wei XH; Li SJ; Liu Y; Hu HL; Li ZZ; Kuang XH; Wang L; Shi X; Yuan ST; Sun L
Cell Commun Signal; 2018 Dec; 16(1):100. PubMed ID: 30563531
[TBL] [Abstract][Full Text] [Related]
15. Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 2 Expression in Brain Arteriovenous Malformations and its Association with Brain Arteriovenous Malformation Size.
Neyazi B; Tanrikulu L; Wilkens L; Hartmann C; Stein KP; Dumitru CA; Sandalcioglu IE
World Neurosurg; 2017 Jun; 102():79-84. PubMed ID: 28279775
[TBL] [Abstract][Full Text] [Related]
16. PLOD2-driven IL-6/STAT3 signaling promotes the invasion and metastasis of oral squamous cell carcinoma via activation of integrin β1.
Saito K; Mitsui A; Sumardika IW; Yokoyama Y; Sakaguchi M; Kondo E
Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33887877
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of PLOD2 induced osimertinib resistance in non-small cell lung cancer HCC827 cells].
Kang XH; Wang K; Wang Y; Zhao HK; Zhang J; Zhao KL; Miao ZH; Xu ZY; Cao F; Gong YB
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):210-215. PubMed ID: 32252199
[No Abstract] [Full Text] [Related]
18. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma.
Jiang H; Guo W; Yuan S; Song L
Biomed Res Int; 2020; 2020():3418398. PubMed ID: 33134376
[TBL] [Abstract][Full Text] [Related]
19. TRAF6 correlated to invasion and poor prognosis of glioblastoma via elevating MMP9 expression.
Sun J; Zhao B; Du K; Liu P
Neuroreport; 2019 Jan; 30(2):127-133. PubMed ID: 30571666
[TBL] [Abstract][Full Text] [Related]
20. [Expression of PLOD2 in esophageal squamous cell carcinoma and its correlation with invasion and metastasis].
Di WY; Kang XH; Zhang JH; Wang Y; Kou WZ; Su W
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):102-107. PubMed ID: 30695860
[No Abstract] [Full Text] [Related]
[Next] [New Search]
